Preventing the next pandemic: How vaccine makers reshape serums with R & D?


Some people are working like the COVID-19 pandemic is over, but it is wrong to presume it’s wrap-up. It created havoc all over the world. However, it also showed the resilience of several vaccine exporters from India who produced serums on-demand for global use. Unfortunately, not all sections of society got COVID-19 injections in equal measure. The focus is now on R & D to ensure that new inoculations are more powerful and also distributed uniformly. Moreover, it is now necessary to prevent large-scale pandemics.

 

Lotus International is in the business of producing several injections to prevent infections harming human life. With strong manufacturing capabilities, it continues to deliver vaccines from India in major markets where other endemics are frequent.

 

We give importance to our lab trials, briefs of global customers and in-depth research. This is our answer to reshape vaccines for better results, and healthy people worldwide.

 

A telescopic view

 

We allhave learned lessons and today more than 20 different vaccines are under various stages of developmentglobally only for COVID-19. For the last few decades, various brands have been instrumental in preventing other life-threatening infections and viruses. Pharma and the biotech industry understand the significance of preventing deaths by administrating the right inoculations. This is possible mainly due to rapid research and development avaluable factor for the creation of a vaccine cycle. It is a continuous exploration that enables manufacturers to be on the forefrontwhen pandemics occur. The threat of the next wave and risks cannot be stopped. Manufacturers are bridging the gap by sharing data, trials, and reports encouraging cross-fertilization of ideas, including information related to the safety of new vaccines.

 

Aiming to find the best shot!

 

Before a new vaccine is introduced publically, various processes are undertaken in clinical laboratories and research centers. Testing is a critical part to ensure safety and its effectiveness. As reputed vaccine exporters from India, we understand the three phases of trials conducted to make the product for the dosage.

 

Once the product passes each phase successfully the prototype is dispatched by an organized supply chain. Each trial involves healthy volunteers for the project. Researchers check how the human body responds with or without side effects.

 

Our products are already active in the global markets

 

Imovax Polio

Poliomyelitis vaccine is used to prevent the disease of Polio in infants and children. It contains weakened poliovirus and is injected into the muscle of the leg or arm. Due to the introduction of a weakened virus in the body, our immune system produces antibodies providing us with a lifelong immunity against this disease.

 

Okavax

Live attenuated Varicella-zoster Vaccine (Oka strain) is used to protect the human body against Varicella and is present as a lyophilized virus. The presence of hydrolyzed gelatine and sucrose helps fight Varicella.

 

Pentaxim

 

Pentaxim blocks the development of arthritis, osteomyelitis, epiglottis, pneumotherapy, meningitis, cellulitis, and septicemia in the body. It is meant for children of age 6 weeks to 2 years.

 

Lotus International is supporting several scientists based in other countries and pharma companies by researching to prepare for immunization. As vaccine exporters from India, our products meet safety, reliability, and effectiveness.

 

 

 

READ ALL BLOG ARTICLES